In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Integrated Diagnostics begins operations with $30mm Series A

Executive Summary

Integrated Diagnostics (blood tests using a systems biology approach) has officially started operations and concurrently raised $30mm in its Series A financing from lead investor InterWest Partners, which was joined by the Wellcome Trust and dievini Hopp Biotech. The financing will occur in three tranches, the first of which, totalling $10mm, has been received.

Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies